Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson buys Heartport for $81 million

This article was originally published in Clinica

Executive Summary

Heartport, the less invasive cardiac surgery company, which has never delivered on its early promise in face of the shift to beating heart surgery, has been acquired by Johnson & Johnson for J&J shares totalling $81 million - or $2.72 a share. Heartport will become a wholly owned subsidiary operating as part of the Ethicon Worldwide surgical instruments division of J&J.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel